SELCT MED HLDGS
SELCT MED HLDGS operates in Diversified Metals & Mining.
SELCT MED HLDGS (S24) - Net Assets
Latest net assets as of September 2024: €2.30 Billion EUR
Based on the latest financial reports, SELCT MED HLDGS (S24) has net assets worth €2.30 Billion EUR as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.00 Billion) and total liabilities (€5.70 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €2.30 Billion |
| % of Total Assets | 28.75% |
| Annual Growth Rate | 8.21% |
| 5-Year Change | 69.42% |
| 10-Year Change | N/A |
| Growth Volatility | 28.44 |
SELCT MED HLDGS - Net Assets Trend (2016–2023)
This chart illustrates how SELCT MED HLDGS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SELCT MED HLDGS (2016–2023)
The table below shows the annual net assets of SELCT MED HLDGS from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €1.57 Billion | +13.19% |
| 2022-12-31 | €1.39 Billion | +1.88% |
| 2021-12-31 | €1.36 Billion | -17.33% |
| 2020-12-31 | €1.65 Billion | +77.73% |
| 2019-12-31 | €929.03 Million | +1.40% |
| 2018-12-31 | €916.24 Million | -1.75% |
| 2017-12-31 | €932.60 Million | +2.95% |
| 2016-12-31 | €905.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to SELCT MED HLDGS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 102.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €751.86 Million | 58.36% |
| Other Components | €536.45 Million | 41.64% |
| Total Equity | €1.29 Billion | 100.00% |
SELCT MED HLDGS Competitors by Market Cap
The table below lists competitors of SELCT MED HLDGS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OCEANAGOLD
MU:RQQ
|
$117.20K |
|
49 North Resources Inc
PINK:FNINF
|
$117.21K |
|
ELET5F
SA:ELET5F
|
$117.26K |
|
PEARSON
BE:PES
|
$117.34K |
|
QUINSTREET
BE:5Q8
|
$117.09K |
|
Lombard Street Capital Corp.
V:LSC-P
|
$117.02K |
|
SALLY BEAUTY (S7V.SG)
STU:S7V
|
$116.96K |
|
Grosvenor CPC I Inc.
V:GRVA-P
|
$116.94K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SELCT MED HLDGS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 1,121,922,000 to 1,288,304,000, a change of 166,382,000 (14.8%).
- Net income of 243,491,000 contributed positively to equity growth.
- Dividend payments of 63,904,000 reduced retained earnings.
- Share repurchases of 12,759,000 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €243.49 Million | +18.9% |
| Dividends Paid | €63.90 Million | -4.96% |
| Share Repurchases | €12.76 Million | -0.99% |
| Other Changes | €-446.00K | -0.03% |
| Total Change | €- | 14.83% |
Book Value vs Market Value Analysis
This analysis compares SELCT MED HLDGS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.25x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.04x to 1.25x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €6.14 | €12.50 | x |
| 2018-12-31 | €5.94 | €12.50 | x |
| 2019-12-31 | €5.74 | €12.50 | x |
| 2020-12-31 | €7.86 | €12.50 | x |
| 2021-12-31 | €8.29 | €12.50 | x |
| 2022-12-31 | €8.82 | €12.50 | x |
| 2023-12-31 | €10.04 | €12.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SELCT MED HLDGS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 18.90%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.65%
- • Asset Turnover: 0.87x
- • Equity Multiplier: 5.97x
- Recent ROE (18.90%) is below the historical average (20.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 14.15% | 2.69% | 0.87x | 6.06x | €33.84 Million |
| 2017 | 21.52% | 3.99% | 0.87x | 6.23x | €94.85 Million |
| 2018 | 17.16% | 2.71% | 0.85x | 7.43x | €57.54 Million |
| 2019 | 19.25% | 2.72% | 0.74x | 9.52x | €71.35 Million |
| 2020 | 24.42% | 4.68% | 0.72x | 7.22x | €152.95 Million |
| 2021 | 36.24% | 6.48% | 0.84x | 6.63x | €291.23 Million |
| 2022 | 14.17% | 2.51% | 0.83x | 6.83x | €46.80 Million |
| 2023 | 18.90% | 3.65% | 0.87x | 5.97x | €114.66 Million |
Industry Comparison
This section compares SELCT MED HLDGS's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SELCT MED HLDGS (S24) | €2.30 Billion | 14.15% | 2.48x | $117.09K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |